Research interpretation, not diagnosis or personal treatment advice. Urgent symptoms belong with a clinician, not a browser tab.
Evidence before optimism

Which longevity interventions have actually worked in humans?

A practical evidence map for supplements, healthspan interventions and ageing research. Human outcomes are separated from biomarkers, animal lifespan studies and mechanistic promise.

Evidence snapshot

Interesting does not mean established

Each profile gives human outcomes, biomarker evidence, animal lifespan work, mechanism, safety certainty and direct relevance to longevity separate scores.

Amino acid derivative

Taurine

Promising, incomplete

Compelling animal ageing biology; human longevity claims remain untested.

Performance and muscle

Creatine monohydrate

Useful human evidence

Useful evidence for strength and training support; longevity benefits would be indirect.

Amino acids and redox biology

GlyNAC

Early human evidence

Small human studies are intriguing, but the claims currently outrun the sample sizes.

NAD+ precursor

NMN

Early human evidence

Raises NAD-related biomarkers; broad healthspan benefits have not followed reliably.

Vitamin and deficiency correction

Vitamin D

Useful human evidence

Important when deficient; extra supplementation is not a universal longevity multiplier.

Cardiometabolic

Omega-3 fatty acids

Useful human evidence

Some cardiovascular effects are real, but formulation, dose and baseline risk matter greatly.

Three useful tools

A site with jobs to do

No infinite scroll of generic wellness copy. The database, trial radar and stack audit each answer a different practical question.

01

Evidence matrix

Compare clinical outcomes, biomarkers, animal lifespan evidence, safety and direct longevity relevance.

Browse the matrix →
02

Human trial radar

Track registered studies and published results without pretending that registration guarantees success.

Open trial radar →
03

Supplement stack audit

Find duplication, timing issues, weakly tested combinations and the annual cost of chemical optimism.

Audit a stack →
Editorial position

The uncertainty stays on the page

  • Human outcomes are not replaced with molecular mechanism when the trial result is disappointing.
  • Animal lifespan evidence is labelled as animal lifespan evidence.
  • Study doses are recorded descriptively, not converted into personal prescriptions.
  • Conflicts of interest and commercial dependence are treated as relevant context.
  • Negative and null findings remain visible.
“A molecule can be biochemically fascinating, commercially successful and clinically unproven at the same time.”
Editorial principle, Longevity Evidence Lab

Start with the intervention you already take

Find out which claims rest on human outcomes and which are still being carried by rodents and optimism.

Search the evidence